|
RAB2A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
9.44450000428532E-08 |
| Normal-vs-Stage3 |
1.84097181943343E-12 |
| Normal-vs-Stage4 |
3.89959953217556E-10 |
| Stage1-vs-Stage2 |
9.440200E-01 |
| Stage1-vs-Stage3 |
2.259400E-01 |
| Stage1-vs-Stage4 |
5.907400E-01 |
| Stage2-vs-Stage3 |
4.014400E-01 |
| Stage2-vs-Stage4 |
6.622400E-01 |
| Stage3-vs-Stage4 |
6.618000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
1.66966440673377E-12 |
| Normal-vs-Asian |
9.488400E-02 |
| Caucasian-vs-AfricanAmerican |
1.581790E-01 |
| Caucasian-vs-Asian |
5.845400E-01 |
| AfricanAmerican-vs-Asian |
2.401600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.11022302462516E-16 |
| Normal-vs-Female |
2.12641015906456E-12 |
| Male-vs-Female |
2.262400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.09949998789483E-09 |
| Normal-vs-Age(41-60Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(81-100Yrs) |
3.224800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.122000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.860400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.978200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.639400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.379400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.062800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.054400E-02 |
| Normal-vs-Grade 2 |
1.63635771599502E-12 |
| Normal-vs-Grade 3 |
<1E-12 |
| Normal-vs-Grade 4 |
5.99764682363002E-12 |
| Grade 1-vs-Grade 2 |
1.428580E-01 |
| Grade 1-vs-Grade 3 |
2.812400E-02 |
| Grade 1-vs-Grade 4 |
4.264200E-02 |
| Grade 2-vs-Grade 3 |
4.397800E-02 |
| Grade 2-vs-Grade 4 |
9.096300E-02 |
| Grade 3-vs-Grade 4 |
7.847000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.63014046705712E-12 |
| Normal-vs-ccB subtype |
3.56492613207138E-13 |
| ccA subtype-vs-ccB subtype |
8.361000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.99200722162641E-16 |
| Normal-vs-N1 |
2.112000E-02 |
| N0-vs-N1 |
8.131800E-01 |
|
|
